SYLVANT
Google image searchProduct monograph
Active ingredient
siltuximab, 400 MG/VIAL
DIN: 02435136
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription / Schedule D
Company: RECORDATI RARE DISEASES CANADA INC
Date: 30-JUL-2024
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AC — Interleukin inhibitors (ATC, ATC/DDD)
- L04AC11 — SILTUXIMAB (ATC/DDD)
